UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
Under the Securities Exchange Act of 1934
(Amendment No. 9)
Merge Healthcare Incorporated
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
589499102
(CUSIP Number)
Merrick RIS, LLC
350 North Orleans Street
10th Floor
Chicago, Illinois 60654
(312) 994-9494
With a Copy to:
Sanford E. Perl, P.C.
Gerald T. Nowak, P.C.
Kirkland & Ellis LLP
300 North LaSalle Street
Chicago, Illinois 60654
(312) 862-2000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
March 14, 2013
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO. | 589499102 | | 13D | Page 3 |
1 | NAME OF REPORTING PERSON |
Merrick RIS, LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(b) þ |
3 | SEC USE ONLY |
|
4 | SOURCE OF FUNDS |
WC |
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
o |
6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
Delaware |
| 7 | SOLE VOTING POWER |
| | 0 |
| | |
SHARES | 8 | SHARED VOTING POWER |
| | 0 |
OWNED BY | | |
| 9 | SOLE DISPOSITIVE POWER |
REPORTING | | 0 |
| | |
WITH | 10 | SHARED DISPOSITIVE POWER |
| | 0 |
| | |
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
0 |
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
o |
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
0% |
14 | TYPE OF REPORTING PERSON |
OO |
CUSIP NO. | 589499102 | | 13D | Page 4 |
1 | |
Merrick Venture Management, LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(b) þ |
3 | SEC USE ONLY |
|
4 | SOURCE OF FUNDS |
|
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
o |
6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
|
| 7 | |
| | 0 |
| | |
SHARES | 8 | |
| | 0 |
OWNED BY | | |
| 9 | |
REPORTING | | 0 |
| | |
WITH | 10 | |
| | 0 |
| | |
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
o |
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 |
|
14 | |
|
CUSIP NO. | 589499102 | | 13D | Page 5 |
1 | |
|
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(b) þ |
3 | SEC USE ONLY |
|
4 | SOURCE OF FUNDS |
|
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
o |
6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
|
| 7 | |
| | |
| | |
SHARES | 8 | |
| | |
OWNED BY | | |
| 9 | |
REPORTING | | |
| | |
WITH | 10 | |
| | |
| | |
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
o |
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 |
|
14 | |
|
CUSIP NO. | 589499102 | | 13D | Page 6 |
1 | |
Merrick Venture Management Holdings, LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(b) þ |
3 | SEC USE ONLY |
|
4 | SOURCE OF FUNDS |
|
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
o |
6 | CITIZENSHIP OR PLACE OF ORGANIZATION |
|
| 7 | |
| | |
| | |
SHARES | 8 | |
| | |
OWNED BY | | |
| 9 | |
REPORTING | | |
| | |
WITH | 10 | |
| | |
| | |
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON |
|
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |
o |
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
|
14 | |
|
CUSIP NO. | 589499102 | | 13D | Page 7 |
TABLE OF CONTENTS
ITEM 1. SECURITY AND ISSUER |
|
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION |
|
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER |
|
ITEM 7. MATERIAL TO BE FILED AS AN EXHIBIT |
|
SIGNATURES |
|
EXHIBIT INDEX |
|
EX-99.6 |
CUSIP NO. | 589499102 | | 13D | Page 8 |
ITEM 1. | SECURITY AND ISSUER |
The following constitutes Amendment No. 9 (“Amendment No. 9”) to the Schedule 13D (the original Schedule 13D, as amended prior to the date hereof, is referred to herein as the “Schedule 13D”) filed by the undersigned with the Securities and Exchange Commission (the “SEC”) on June 16, 2008. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms as set forth in the Schedule 13D.
Amendment No. 9 is being filed to report changes in the beneficial ownership of the Reporting Persons as a result of the distribution of shares of Common Stock of Merge Healthcare Incorporated (“Merge” or the “Company”) by Merrick Venture Management Holdings, LLC (“MVMH”) and Merrick Venture Management, LLC (“MVM”) to a private company.
ITEM 3. | SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. |
Item 3 of the Schedule 13D is hereby supplemented as follows:
On March 14, 2013, MVM obtained the right to deliver shares of common stock in settlement of the outstanding balance of a promissory note entered into by MVM in exchange for securities of a private company and the delivery of shares of common stock in settlement thereof. On March 18, 2013, MVMH and MVM each disposed of 1,906,175 shares of Merge common stock in connection with the derivative securities owned by MVM. As of the opening of trading on the filing date of this Amendment No. 9, Michael W. Ferro, Jr. ("Ferro") beneficially owned 27,631,298 shares of Common Stock (including options covering 600,000 shares of Common Stock that are currently exercisable or will become exercisable within sixty (60) days of March 14, 2013).
ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER. |
Item 5 (a), (b), and (c) of the Schedule 13D are hereby amended and restated as follows:
(a), (b) As of the opening of trading on the filing date of this Amendment No. 9, Ferro is deemed to have sole voting and dispositive power over the shares of Common Stock directly owned by the following entities which he controls:
Name of Holder | Number of Shares | Percent of Shares Outstanding |
Merrick RIS, LLC | 0 | 0.0% |
Merrick Venture Management, LLC | 0 | 0.0% |
Merrick Ventures, LLC | 4,925,441 | 5.3% |
Merrick Venture Management Holdings, LLC | 22,105,857 | 23.7% |
In addition, Ferro holds options covering 600,000 shares of Common Stock that are currently exercisable or will become exercisable within sixty (60) days of March 14, 2013. Ferro does not directly own any shares of Common Stock. Ferro disclaims beneficial ownership of the shares of Common Stock deemed to be beneficially owned by him, except to the extent of his pecuniary interest in such shares. The ownership percentages are calculated based on 93,459,177 shares of Common Stock as reported by the Company to be outstanding as of March 5, 2013 in its Annual Report on Form 10-K filed with the SEC on March 11, 2013.
(c) Except for the transactions described above and elsewhere in this Schedule 13D, during the last sixty (60) days, there were no transactions in shares of the Common Stock of the Company effected by the Reporting Persons.
CUSIP NO. | 589499102 | | 13D | Page 9 |
ITEM 7. | MATERIAL TO BE FILED AS AN EXHIBIT |
Exhibit 1 | Joint Filing Agreement |
CUSIP NO. | 589499102 | | 13D | Page 10 |
SIGNATURES
After reasonable inquiry and to the best of the undersigned’s knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.
Date: April 2, 2013 | MERRICK RIS, LLC | |
| | |
| By: | /s/ Michael W. Ferro, Jr. | |
| Name: | Michael W. Ferro, Jr. | |
| Title: | Chief Executive Officer | |
| | | |
| MERRICK VENTURE MANAGEMENT, LLC | |
| | |
| By: | /s/ Michael W. Ferro, Jr. | |
| Name: | Michael W. Ferro, Jr. | |
| Title: | Chief Executive Officer | |
| | | |
| MERRICK VENTURE MANAGEMENT HOLDINGS, LLC | |
| | | |
| By: | /s/ Michael W. Ferro, Jr. | |
| Name: | Michael W. Ferro, Jr. | |
| Title: | Managing Member | |
| | | |
| By: | /s/ Michael W. Ferro, Jr. | |
| | Michael W. Ferro, Jr. | |
EXHIBIT INDEX